BBusiness Read More Novo Nordisk sues Eli Lilly over GLP-1 adsJuly 21, 2026 Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group…
HHealth care Read More What to know about testosterone replacement therapyJuly 20, 2026 US Secretary of Defense Pete Hegseth speaks during a press briefing at the Pentagon in Washington, DC, on…
BBusiness Read More Market for psychedelic drugs to treat mental health gets a buy signalJuly 19, 2026 Psilocybin mushrooms stand ready for harvest in a humidified “fruiting chamber.” John Moore | Getty Images Thursday’s announcement…
MMedication Read More Ozempic for cats? GLP-1 weight-loss drugs are coming for your fat petJuly 18, 2026 A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark |…
HHealth care Read More Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billionJuly 16, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
BBusiness Read More UnitedHealth Group (UNH) earnings Q2 2026July 16, 2026 UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as…
HHealth care Read More Johnson & Johnson (JNJ) Q2 earningsJuly 15, 2026 Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from…
HHealth care Read More Johnson & Johnson has a chance to show it’s more than just a rotation winnerJuly 14, 2026 Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…
HHealth care Read More GLP-1 implant from Vivani Medical aims to help patients stay on treatmentJuly 11, 2026 Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
HHealth care Read More AstraZeneca stock dives 9% after heart drug trial misses targetJuly 9, 2026 Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed…
HHealth care Read More Employers aren’t expanding coverage of GLP-1 obesity drugs: surveyJuly 8, 2026 A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
BBusiness Read More Medicare obesity drug GLP-1 coverage starting July 1June 30, 2026 Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…